Skip to content

Drug interactions

Clemastine + Finerenone

Severity: Minor

Clemastine and Finerenone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Finerenone is a CYP3A4 substrate, and clemastine is listed as a weak CYP3A4 inhibitor, so finerenone exposure could rise modestly. Higher exposure may increase the risk of hyperkalemia.

What this interaction means in plain words

Clemastine and Finerenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Clemastine belongs to Respiratory; Finerenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition may reduce finerenone metabolism.

What to do

Check serum potassium when starting or changing clemastine in patients taking finerenone. Adjust the finerenone dose if potassium rises.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clemastine and Finerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Clemastine with Finerenone?

MediHelp rates the interaction as minor. Clemastine and Finerenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Finerenone is a CYP3A4 substrate, and clemastine is listed as a weak CYP3A4 inhibitor, so finerenone exposure could rise modestly. Higher exposure may increase the risk of hyperkalemia.

How serious is the interaction between Clemastine and Finerenone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check serum potassium when starting or changing clemastine in patients taking finerenone. Adjust the finerenone dose if potassium rises.

What other medicines interact with Clemastine?

MediHelp also lists interactions of Clemastine with, for example, Alfentanil, Benzhydrocodone / acetaminophen, Buprenorphine buccal. The full list is on the Clemastine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in